Brussels (Brussels Morning Newspaper) – The European Investment Bank (EIB) is providing €35 million to Italy’s GVM hospital group, supporting medical R&D, innovation, and digital infrastructure for improved healthcare services.
The European Investment Bank (EIB) has revealed a financing operation of around €35 million to fund research, development and innovation schemes at GVM, one of Italy’s major hospital groups. The package is supported by InvestEU, the EU’s investment programme.
As reported by EIB, the financing will let GVM design medical technologies in the cardiopulmonary domain and for extracorporeal life support. It will also allow the group to conduct translational and clinical research for cardiovascular and metabolic diseases and to support digital infrastructure in all the group’s leading healthcare structures in Italy.
“This endeavour is funding research and the development of the latest medical technologies, allowing to creation of a more resilient, efficient and modern healthcare approach. Financing in innovation and digitalisation in the healthcare sector is important to enhance its operational efficiency and to ensure that it can react quickly and effectively to prospective challenges,”
stated EIB Vice-President Gelsomina Vigliotti.
“The company has always been concentrated on enhancing the quality and range of its services for the advantage of our patients and service users. We do so by creating substantial investments to develop our facilities, as well as funding in technology, digitalisation, research and the latest organisational resolutions. We are celebrated to have such a long-standing association with the EIB. Thanks to this, we will be capable of carrying out some development schemes in multiple areas. This will allow us to scale up our production of new technologies, conduct more research, and increase the care services that we offer. This will all be accomplished dynamically and innovatively to ensure we capture important opportunities,”
said President of GVM Ettore Sansavini.
